Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. [electronic resource]
- Gastroenterology Mar 2005
- 636-41 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0016-5085
10.1053/j.gastro.2004.12.049 doi
Adult Aged Antiviral Agents--therapeutic use Cohort Studies Drug Therapy, Combination Female Genotype Hepatitis C, Chronic--complications Humans Insulin Resistance Interferon alpha-2 Interferon-alpha--therapeutic use Liver Cirrhosis--virology Male Middle Aged Polyethylene Glycols--therapeutic use Recombinant Proteins Ribavirin--therapeutic use Treatment Outcome Viral Load Viremia--physiopathology